Remus Pharmaceuticals Limited

₹815.00As of Sun 8 Nov 2026, 12:00 UTC
NSE:REMUSHealthcare
Country India
PE (Fwd) •••
TSR 3Y CAGR 41.56%
Div yield 0.12%
ROE 10.76%
Medical (Pharmaceuticals)
Beta (5Y) 0.36
PE TTM 24.13
TSR TTM 13.45%
Mkt cap ₹9.604B
ROIC 8.27%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹952
16.86%
68.71%
Hold 0|9|2|11|1
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
9.03
8.66
8.43
9.41
(0.85%)
(4.01%)
(10.10%)
1.46%
Revenue₹B
0.944
0.993
1.046
1.071
13.42%
16.85%
22.35%
19.99%
Peers (US$102.1M)
Cap (US$)
PE
156.1M
25.76x
45.63M
35.27x
Capital
TTM
5Y
10Y
Leveragex
0.223
0.104
0.099
EBIT/Intx
0.818
1.012
0.857
Own earn%
(102.96)
24.79
22.04
Sh yield%
23.53
38.00
40.09
Owners
Insiders/Inst%
14.97
48.92
Short interest%
1.33
SBC / revenue%
1.15
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
0–5
$1 testx
0.0
Incr. ROIC%
12